Enzymatic deposition of gold nanoparticles at vertically aligned carbon nanotubes for electrochemical stripping analysis and ultrasensitive immunosensing of carcinoembryonic antigen

Dual-channel, real-time, long-term stable electrochemical immunosensor based on Au, Cu-vertical graphene for detection of carcinoembryonic antigen in tumor cells

BACKGROUND

The accurate and rapid determination of a broad-spectrum tumor marker, carcinoembryonic antigen (CEA), in tumor cells, human tissues, and body fluids is important for the early diagnosis, drug development, efficacy evaluation, and prognosis tracking of cancer.

RESULTS

In this study, a dual-channel electrochemical immunosensor was designed for the sensitive determination of CEA levels using an Au-AuCu-vertical graphene (VG) sensing platform. An AuCu bimetallic doping strategy was adopted to improve the biocompatibility of graphene with the cells, and Au nanoparticles were electrodeposited to firmly bind numerous CEA antibodies. The immunosensor exhibited a broad limit of linearity from 0.001 to 30000 pg mL-1 and a low limit of detection of 0.28 fg mL-1. This immunosensor exhibited excellent selectivity, reproducibility, and long-term stability. The developed Au-AuCu-VG-based immunosensor pen combined with self-designed electrochemical immunoassay software achieved high-precision real-time on-site analysis of CEA concentrations.

SIGNIFICANCE

The proposed AuCu-VG electrode exhibited antibody-binding ability, inherent probe peak, and excellent binding of the Au NPs. A new dual-channel electrochemical immunoassay strategy was developed based on the AuCu-VG electrode, which could sensitively and reliably detect the real-time concentration of CEA released by tumor cells, such as MCF-7.

Early Detection and Monitoring of Nephrolithiasis: The Potential of Electrochemical Sensors

Nephrolithiasis (kidney stone disease) continues to pose a significant global health challenge, affecting millions of individuals and placing substantial economic pressures on healthcare systems. Traditional diagnostic methods-such as computed tomography (CT), ultrasound, and basic urinalysis-are often limited by issues including radiation exposure, lower sensitivity in detecting small stones, operator dependency, and the inability to provide real-time analysis. In response, electrochemical sensors have emerged as innovative and powerful tools capable of the rapid, sensitive, and specific detection of key biomarkers associated with nephrolithiasis. This review highlights the advances in electrochemical approaches for monitoring oxalate and uric acid, the two primary metabolites implicated in kidney stone formation. We discuss the principles of electrode design and fabrication, including nanomaterial integration, 3D printing, and molecular imprinting, which have markedly improved detection limits and selectivity. Furthermore, we critically evaluate the practical challenges-such as sensor fouling, reproducibility, and stability in complex biological matrices-that currently impede widespread clinical implementation. The potentials for miniaturization and point-of-care integration are emphasized, with an eye toward continuous or home-based monitoring systems that can offer personalized insights into risk of stone formation and progression. By consolidating recent findings and exploring future trends in multi-analyte detection and wearable diagnostics, this review provides a roadmap for translating electrochemical sensors from research laboratories to routine clinical practice, ultimately aiming to enhance early intervention and improve patient outcomes in nephrolithiasis.

Advances in Surface-Enhanced Raman Spectroscopy for Urinary Metabolite Analysis: Exploiting Noble Metal Nanohybrids

This review examines recent advances in surface-enhanced Raman spectroscopy (SERS) for urinary metabolite analysis, focusing on the development and application of noble metal nanohybrids. We explore the diverse range of hybrid materials, including carbon-based, metal-organic-framework (MOF), silicon-based, semiconductor, and polymer-based systems, which have significantly improved SERS performance for detecting key urinary biomarkers. The principles underlying SERS enhancement in these nanohybrids are discussed, elucidating both electromagnetic and chemical enhancement mechanisms. We analyze various fabrication methods that enable precise control over nanostructure morphology, composition, and surface chemistry. The review critically evaluates the analytical performance of different hybrid systems for detecting specific urinary metabolites, considering factors such as sensitivity, selectivity, and stability. We address the analytical challenges associated with SERS-based urinary metabolite analysis, including sample preparation, matrix effects, and data interpretation. Innovative solutions, such as the integration of SERS with microfluidic devices and the application of machine learning algorithms for spectral analysis, are highlighted. The potential of these advanced SERS platforms for point-of-care diagnostics and personalized medicine is discussed, along with future perspectives on wearable SERS sensors and multi-modal analysis techniques. This comprehensive overview provides insights into the current state and future directions of SERS technology for urinary metabolite detection, emphasizing its potential to revolutionize non-invasive health monitoring and disease diagnosis.

The effect of gold nanostructure morphology on label-free electrochemical immunosensor design

In this research, various electrodeposition techniques were used to form gold nanostructures (AuNSs) on the surface of graphite rod electrode (GE). Three distinct AuNS morphologies on GE have been achieved based on the composition of electrodeposition solution. The use of H2SO4 as a supporting electrolyte resulted in the formation of smaller but more numerous AuNSI with a modified electrode's electroactive surface area (EASA) of 0.213 cm2. Exchanging the supporting electrolyte to KNO3 and increasing HAuCl4 concentration facilitated the formation of bigger AuNSII particles with electrode EASA of 0.116 cm2. Finally, a partial coverage of GE by branched gold nanostructures (AuNSIII) was achieved with an estimated EASA of 0.110 cm2, when the HAuCl4 and KNO3 concentrations were increased further. Estimated values of heterogeneous electron transfer rate constant did not depend on AuNS morphology. Electrode modified with AuNSI exhibited the highest bovine serum albumin (BSA) immobilization efficiency and the highest relative response for the detection of specific polyclonal antibodies against BSA (p-anti-BSA) compared to other modified electrodes. The limit of p-anti-BSA detection in PBS buffer was calculated as 0.63 nM, while in blood serum it was 0.71 nM. Linear ranges were from 1 to 7 nM and from 1 to 5 nM, respectively.

Dual-Mode Electrochemical Competitive Immunosensor Based on Cd2+/Au/Polydopamine/Ti3C2 Composite and Copper-Based Metal-Organic Framework for 17β-Estradiol Detection

Herein, a dual-mode electrochemical competitive immunosensor was constructed for the detection of 17β-estradiol (E2) based on differential pulse voltammetry (DPV) and chronoamperometry (i-t). During the immune recognition process, the E2 antibody (E2-Ab) was immobilized on the Cd²⁺/Au/polydopamine/Ti₃C₂ (Cd²⁺/Au/pDA/Ti₃C₂) composite-modified electrode; then, the E2-conjugated bovine serum albumin (E2-BSA) was labeled with a copper-based metal-organic framework (Cu-MOF) and competed with E2 in combining the E2-Ab. The Cu-MOF was not only an electroactive species but also possessed good electrocatalytic activity toward H₂O₂. Thus, E2 could be quantified according to the peak current change of the Cu-MOF in DPV curve or the variation of H₂O₂ reduction current. For DPV quantification, Cd²⁺ was introduced as an internal reference in this case, and a highly reproducible ratio readout was obtained. The as-prepared dual-mode E2 electrochemical immunosensor showed good linear relationship in the ranges of 1 pg mL^-1-10 ng mL^-1 (DPV) and 10 pg mL^-1-10 ng mL^-1 (i-t), and the detection limits were 0.47 and 5.4 pg mL^-1 (S/N = 3), respectively. Furthermore, the dual-mode electrochemical immunosensor exhibited good practicability in real sample analysis.

Preparation of Graphene Quantum Dots by Visible-Fenton Reaction and Ultrasensitive Label-Free Immunosensor for Detecting Lipovitellin of Paralichthys Olivaceus

The increasing levels of environmental estrogens are causing negative effects on water, soil, wildlife, and human beings; label-free immunosensors with high specificities and sensitivities are being developed to test estrogeneous chemicals in complex environmental conditions. For the first time, highly fluorescent graphene quantum dots (GQDs) were prepared using a visible-Fenton catalysis reaction with graphene oxide (GO) as a precursor. Different microscopy and spectroscopy techniques were employed to characterize the physical and chemical properties of the GQDs. Based on the fluorescence resonance energy transfer (FRET) between amino-functionalized GQDs conjugated with anti-lipovitellin monoclonal antibodies (Anti-Lv-mAb) and reduced graphene oxide (rGO), an ultrasensitive fluorescent “ON-OFF” label-free immunosensor for the detection of lipovitellin (Lv), a sensitive biomarker derived from Paralichthys olivaceus for environmental estrogen, has been established. The immunosensor has a wide linear test range (0.001–1500 ng/mL), a lower limit of detection (LOD, 0.9 pg/mL), excellent sensitivity (26,407.8 CPS/(ng/mL)), and high selectivity and reproducibility for Lv quantification. The results demonstrated that the visible-Fenton is a simple, mild, green, efficient, and general approach to fabricating GQDs, and the fluorescent “ON-OFF” immunosensor is an easy-to-use, time-saving, ultrasensitive, and accurate detection method for weak estrogenic activity.

Vertically Aligned Carbon Nanotubes as a Unique Material for Biomedical Applications

Vertically aligned carbon nanotubes (VACNTs), a unique classification of CNT, highly oriented and normal to the respective substrate, have been heavily researched over the last two decades. Unlike randomly oriented CNT, VACNTs have demonstrated numerous advantages making it an extremely desirable nanomaterial for many biomedical applications. These advantages include better spatial uniformity, increased surface area, greater susceptibility to functionalization, improved electrocatalytic activity, faster electron transfer, higher resolution in sensing, and more. This Review discusses VACNT and its utilization in biomedical applications particularly for sensing, biomolecule filtration systems, cell stimulation, regenerative medicine, drug delivery, and bacteria inhibition. Furthermore, comparisons are made between VACNT and its traditionally nonaligned, randomly oriented counterpart. Thus, we aim to provide a better understanding of VACNT and its potential applications within the community and encourage its utilization in the future.

A Bifunctional Nanosilver-Reduced Graphene Oxide Nanocomposite for Label-Free Electrochemical Immunosensing

A bi-functional material based on silver nanoparticles (AgNPs)-reduced graphene oxide (rGO) composite for both electrode modification and signal generation is successfully synthesized for use in the construction of a label-free electrochemical immunosensor. An AgNPs/rGO nanocomposite is prepared by a one-pot wet chemical process. The AgNPs/rGO composite dispersion is simply cast on a screen-printed carbon electrode (SPCE) to fabricate the electrochemical immunosensor. It possesses a sufficient conductivity/electroreactivity and improves the electrode reactivity of SPCE. Moreover, the material can generate an analytical response due to the formation of immunocomplexes for detection of human immunoglobulin G (IgG), a model biomarker. Based on electrochemical stripping of AgNPs, the material reveals signal amplification without external redox molecules/probes. Under optimized conditions, the square wave voltammetric peak current is responded to the logarithm of IgG concentration in two wide linear ranges from 1 to 50 pg.ml-1 and 0.05 to 50 ng.ml-1, and the limit of detection (LOD) is estimated to be 0.86 pg.ml-1. The proposed immunosensor displays satisfactory sensitivity and selectivity. Importantly, detection of IgG in human serum using the immunosensor shows satisfactory accuracy, suggesting that the immunosensor possesses a huge potential for further development in clinical diagnosis.